REFERENCES

1. Pinotti L, Baldi A, Dell’Orto V. Comparative mammalian choline metabolism with emphasis on the high-yielding dairy cow. Nutr Res Rev. 2002;15:315-32.

2. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr. 1994;14:269-96.

3. Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev. 2009;67:615-23.

4. Zuk E, Nikrandt G, Chmurzynska A. Dietary choline intake in European and non-european populations: current status and future trends-a narrative review. Nutr J. 2024;23:68.

5. Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther. 2018;16:559-65.

6. Zeisel SH. Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis. Clin Chem Lab Med. 2013;51:467-75.

7. Sherriff JL, O’Sullivan TA, Properzi C, Oddo JL, Adams LA. Choline, Its potential role in nonalcoholic fatty liver disease, and the case for human and bacterial genes. Adv Nutr. 2016;7:5-13.

8. Simó C, García-Cañas V. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food Funct. 2020;11:6745-76.

9. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-9.

10. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6:e02481.

11. Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448-55.

12. Bae S, Ulrich CM, Neuhouser ML, et al. Plasma choline metabolites and colorectal cancer risk in the women’s health initiative observational study. Cancer Res. 2014;74:7442-52.

13. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63.

14. Roncal C, Martínez-Aguilar E, Orbe J, et al. Trimethylamine-N-oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease. Sci Rep. 2019;9:15580.

15. Kalnins G, Kuka J, Grinberga S, et al. Structure and function of CutC choline lyase from human microbiota bacterium klebsiella pneumoniae. J Biol Chem. 2015;290:21732-40.

16. Rath S, Heidrich B, Pieper DH, Vital M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome. 2017;5:54.

17. Arias N, Arboleya S, Allison J, et al. The relationship between choline bioavailability from diet, intestinal microbiota composition, and its modulation of human diseases. Nutrients. 2020;12:2340.

18. Cai YY, Huang FQ, Lao X, et al. Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis. NPJ Biofilms Microbiomes. 2022;8:11.

19. Cho CE, Aardema NDJ, Bunnell ML, et al. Effect of choline forms and gut microbiota composition on trimethylamine-N-oxide response in healthy men. Nutrients. 2020;12:2220.

20. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012;10:323-35.

21. Li Q, Chen H, Zhang M, Wu T, Liu R, Zhang Z. Potential correlation between dietary fiber-suppressed microbial conversion of choline to trimethylamine and formation of methylglyoxal. J Agric Food Chem. 2019;67:13247-57.

22. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol. 2008;104:305-44.

23. Wilkhoo HS, Reji F, Islam AW, Karawita JA, Shaikh AA. Comparison of short-term and long-term effects of peroral L-carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications. Explor Cardiol. ; doi: 10.37349/ec.2025.101250.

24. Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021;20:301-19.

25. Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A. 2012;109:21307-12.

26. Simons A. FastQC: A quality control tool for high throughput sequence data. Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/ [Last accessed on 24 Apr 2025].

27. Institute DJG. BBDuk: Filters, trims, or masks reads with kmer matches to an artifact/contaminant file. Available from: https://manpages.ubuntu.com/manpages/focal/man1/bbduk.sh.1.html.

28. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357-9.

29. Blanco-Míguez A, Beghini F, Cumbo F, et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat Biotechnol. 2023;41:1633-44.

30. Beghini F, McIver LJ, Blanco-Míguez A, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021:10.

31. Mallick H, Rahnavard A, McIver LJ, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17:e1009442.

32. Team RC. R: A language and environment for statistical computing. In. Vienna, Austria: R Foundation for Statistical Computing; 2023. Available from: https://www.r-project.org/ [Last accessed on 24 Apr 2025].

33. Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45:W180-8.

34. Peschel S, Müller CL, von Mutius E, Boulesteix AL, Depner M. NetCoMi: network construction and comparison for microbiome data in R. Brief Bioinform. 2021:22.

35. Sanders LM, Zeisel SH. Choline: dietary requirements and role in brain development. Nutr Today. 2007;42:181-6.

36. Obeid R, Karlsson T. Choline - a scoping review for nordic nutrition recommendations 2023. Food Nutr Res. 2023:67.

37. Ambrogi V, Bottacini F, Mac Sharry J, et al. Bifidobacterial β-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments. Front Microbiol. 2021;12:750635.

38. Aguilera M, Rakotoarivonina H, Brutus A, Giardina T, Simon G, Fons M. Aga1, the first alpha-galactosidase from the human bacteria ruminococcus gnavus E1, efficiently transcribed in gut conditions. Res Microbiol. 2012;163:14-21.

39. Mei Z, Yuan J, Li D. Biological activity of galacto-oligosaccharides: a review. Front Microbiol. 2022;13:993052.

40. Farthing MJ. Bugs and the gut: an unstable marriage. Best Pract Res Clin Gastroenterol. 2004;18:233-9.

41. Horigome A, Hashikura N, Yoshida K, Xiao JZ, Odamaki T. 2’-fucosyllactose increases the abundance of blautia in the presence of extracellular fucosidase-possessing bacteria. Front Microbiol. 2022;13:913624.

42. Wiese M, Schuren FHJ, Smits WK, et al. 2’-Fucosyllactose inhibits proliferation of clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating clostridioides difficile infection. Front Cell Infect Microbiol. 2022;12:991150.

43. Fusco W, Lorenzo MB, Cintoni M, et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023;15:2211.

44. Guo P, Zhang K, Ma X, He P. Clostridium species as probiotics: potentials and challenges. J Anim Sci Biotechnol. 2020;11:24.

45. Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25:27-42.

46. Dosselaere F, Vanderleyden J. A metabolic node in action: chorismate-utilizing enzymes in microorganisms. Crit Rev Microbiol. 2001;27:75-131.

47. Gao J, Xu K, Liu H, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol. 2018;8:13.